China
China Product Registration and Regulatory Issues Webcast CD
| Publication Date | March 2007 |
| Publisher | Pacific Bridge Medical |
| Product Type | CD-ROM |
| Pages | not applicable |
| ISBN Number | not applicable |
| Product Code | PBM00005 |
Summary
China's pharmaceutical market is currently ninth largest worldwide and worth approximately $20 billion. With analysts predicting this market to be fifth largest by 2010, one cannot ignore China's potential. This webcast will provide an overview of drug registration in China as well as discuss the most recent regulatory issues of the Chinese State Food and Drug Administration (SFDA). This 90-minute session will include a 60-minute presentation, followed by 30 minutes of Q&A.
The following topics will be covered in this webcast:
- Overview of China Healthcare
- China Pharmaceutical Market Industry Overview
- Drug Registration Policy
- Pharmaceutical Manufacturing Regulations
- Classification of Drugs
- Drug Registration Application
- Drug Pricing
- Clinical Trials
- Requirements for product inserts, labeling and packaging
- Good Manufacturing Practice (GMP)
- Good Clinical Practice (GCP)
- Good Laboratory Practice (GLP)
- Post-marketing surveillance and quality control
- Intellectual Property







